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Background: Atherogenic effects of ELF-MF exposure have not been studied well so far. Therefore we have
hypothesized that ELF-MF exposure might have atherogenic effect by impairing antioxidant function and increasing
lipid peroxidation. This study was therefore undertaken to examine the effects of ELF-MF on paraoxonase (PON)
activity, antioxidant capacity and lipid peroxidation metabolites. Effects of time on remodeling of antioxidant system
were also investigated in this study.
Methods: Seventy five Wistar rats were randomly allocated into five groups as follows: 1) Sham exposure, 2) Single
exposure to 60 Hz, sacrificed immediately after exposure, 3) Single exposure to 60 Hz, sacrificed 72 hours after
exposure, 4) Fourteen days of exposure to 60 Hz, sacrificed immediately after exposure, and 5) Fourteen days of
exposure to 60 Hz, sacrificed 72 hours after exposure. Blood samples were collected and analyzed. The results were
compared using ANOVA and post hoc Tukey HSD for multiple caparisons.
Results: Single ELF-MF exposure significantly increased lipid peroxidation (CD and MDA) and increased antioxidant
serum activity (HDL, paraoxonase activity, and serum total antioxidant capacity). Chronic ELF-MF exposure increased
lipid peroxidation and affected antioxidant system. Free fatty acids levels were significantly increased after both
single and two weeks exposure. Chronic exposure led to irreversible changes while acute exposure tended to
reversible alterations on above mentioned parameters.
Conclusions: According to the results of this study, ELF-MF exposure could impair oxidant-antioxidant function and
might increase oxidative stress and lipid peroxidation. Antioxidant capability was dependent on the duration and
continuity of ELF-MF exposure.
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Exposure to extremely low frequency magnetic fields
(ELF-MF) is increased due to modernization and develop-
ment of new electronic devices. Several adverse effects
such as psychological and carcinogenic effects were re-
ported as a result of exposure to extremely low frequency
magnetic fields (ELF-MF) [1,2]. However atherogenic ef-
fects of ELF-MF exposure have not been studied well. It is* Correspondence: sseifirad@gmail.com
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unless otherwise stated.hypothesized that ELF-MF exposure might impair antioxi-
dant systems and increase lipid peroxidation [3-5].
Low density lipoprotein (LDL) oxidation in arterial walls
was suggested as an important mechanism of atheroscler-
osis. On the other hand, antioxidants, high density lipo-
protein (HDL) and paraoxonase (PON) activity are among
the main protective factors of lipid peroxidation and
therefore atherosclerosis. It has been shown that PON de-
creases oxidation sensitivity of LDL [6,7].
To the best of our knowledge, there is no report for in-
vestigating the effects of ELF-MF on PON activity. Also
the results of previous studies on effects of ELF-MF on
lipid peroxidation are still contradictory [3,4,8,9]. ThisLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ELF-MF on PON activity, antioxidant capacity and lipid
peroxidation metabolites. Effects of time on remodeling of
antioxidant system were also investigated in this study.
Materials and methods
Animals
Seventy five 220–250 g adult male Wistar rats were in-
cluded in the study. In order to adapt with temperature,
humidity, and regular light (12 hr)/dark (12 hr) cycle,
the animals were stored for one week in the animal la-
boratory before ELF-MF exposure. The temperature was
set at 23°C and normal food (AIN-93 purified diets for
laboratory rodents) and water was always available in
the animals’ cage.
ELF-MF exposure
Using a modified form of a previously described method,
ELF-MF exposure was set up [10]. We tried to produce
60 Hz frequency and 0.5 mT field using a pair of Helm-
holtz coils which were set with winding surrounded in a
plexi-glass frame. Through a variable transformer the
coils were connected to a 220 V AC power supply. The
centrally horizontal magnetic field was homogenous in a
plexi-glass cage (a non-magnetic material). Sham expos-
ure group were placed in the same cage though the coils
were turned off, being exposed to the local geomagnetic
field (BH = 0.18, BV = 0.22, BT = 0.23) and BAC <
0.02 G). By means of a gauss-meter (Lake Shore, Model
410), the homogeneity in the plexi-glass was determined.
To adjust the frequency and intensity, the coils were
linked to a waveform generator.
Methodology and serum analysis
Seventy five Wistar rats were randomly allocated into
five groups as follows:
1) Sham exposure
2) Single exposure to 60 Hz, sacrificed immediately
after exposure
3) Single exposure to 60 Hz, sacrificed 72 hours after
exposure
4) Fourteen days of Exposure to 60 Hz, sacrificed
immediately after exposure
5) Fourteen days of Exposure to 60 Hz, sacrificed
72 hours after exposure
The rats were sacrificed after anesthesia with diethyl
ether; blood samples were then collected through left ven-
tricle after thoracotomy.
Serum levels of HDL and LDL were measured using
an automated chemical analyzer (Abbott analyzer).
Paraoxonase activity was determined spectrophoto-
metrically using phenylacetate (substrate) and paraoxone(O, O-diethyl-O-P-nitrophenylphosphate) as described pre-
viously [11]. Malondehaldeid (MDA) levels were measured
using thiobarbituric acid (TBA) method based on previous
method [12]. Serum total antioxidant capacity (TA) was
measured spectrophotometerically [TAS kit (“Total Anti-
oxidant Status” – TAS; Randox, Crumlin, UK)].
Enzymatic colorimetric methods (Spectrophotometery)
were used to assess free fatty acids (FFA) levels in blood
samples (not heparinized, centrifuged as soon as possible
and frizzed).
Conjugated diens (CD) levels were also measured spec-
trophotometrically (wavelength range 230–235) [13,14].
Statistical analysis
Kolmogorov-Smirnov test was used to check for the nor-
mality of data distribution. One way ANOVA test was
used to compare HDL, LDL, TA, PON, MDA, FFA, and
CD between groups. For significant variables post hoc
Tukey HSD test was applied to compare between
groups. For five possible comparisons the p value was
set as 0.01 using Bonferroni correction (0.05/5).
Results
Since rats were randomly allocated in five groups, no sig-
nificant differences were observed between the mean
weights of rats. (p value > 0.05). Normal distribution of data
was observed between groups. Serum levels of HDL, LDL,
FFA, TA, CD, MDA, and serum PON1 activity in all stud-
ied groups were shown in Table 1 and Figures 1,2,3,4,5,6,7.
We observed a significant increase in the serum levels
of CD in one time exposed rats (4 hrs, 60 Hz) compared
to the sham exposed group (p value < 0.000). After
72 hours, serum CD levels were decreased and normalized
(p value > 0.05).
A similar pattern was observed in chronic exposed
rats, however the increased CD levels were more
remarkable compared to one time exposed rats
(p value < 0.000).
Serum levels of MDA, as a late marker for peroxida-
tion, were also measured to assess the effect of ELF-MF
exposure on lipid peroxidation. At the end of the study,
MDA levels in one time exposed rats were slightly higher
compared to the control group but the observed differ-
ence was not statistically significant (p value = 0.990). In
chronic ELF-MF exposed group, serum MDA levels were
even higher than the one time exposed group and were
remained high after three days (p value <0.000).
No statistically significant difference in the concentra-
tion of LDL was observed between sham exposed and
one time exposed rats at the end of study. (p value =
0.998) serum LDL levels were not changed after chronic
ELF-MF exposure (p value = 0.983).
However, FFA serum levels were increased after either
acute (one time) (p value <0.000) or chronic (2 weeks)
Table 1 Serum levels of HDL, LDL, FFA, TA, CD, MDA, and serum PON1 activity at the end of the study in all
studied groups
Parameter Sham exposed 4 hrs-suddenly 4 hrs-after 72 hrs 2 W-suddenly 2 W-after 72 hrs
PON1 (U/mL) 105.90 ± 2.91* 115.20 ± 3.50 106.90 ± 3.93 96.76 ± 2.89 101.43 ± 3.79
MDA (nmol/mL) 1.77 ± 0.21 1.81 ± 0.23 1.84 ± 0.22 2.40 ± 0.25 2.36 ± 0.26
CD (mg/dL) 2.37 ± 0.21 2.58 ± 0.19 2.35 ± 0.20 2.95 ± 0.18 2.42 ± 0.18
HDL (mg/dL) 25.13 ± 0.83 26.93 ± 96 25.70 ± 0.84 24.06 ± 0.96 24.73 ± 0.67
LDL (mg/dL) 51.70 ± 0.70 51.66 ± 0.77 51.70 ± 0.81 51.93 ± 2.12 51.60 ± 0.82
FFA (mg/dL) 12.60 ± 1.58 15.80 ± 1.78 13.53 ± 1.99 17.26 ± 2.18 13.66 ± 1.59
TA (mg/dL) 1.72 ± 0.13 2.03 ± 0.12 1.17 ± 0.11 1.28 ± 13 1.36 ± 0.15
*Mean ± Standard deviation.
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increased lipid metabolism after ELF-MF exposure. After
72 hours, serum levels of FFA were normalized. There
were no significant difference between the serum FFA
levels of acute (p value = 0.638) and chronic (p value =
0.511) ELF-MF exposed rats after 72 hours compared to
the sham exposed rats.
Serum HDL levels were increased after one time ex-
posure (p value <0.000) while chronic exposure to ELF-
MF decreased HDL serum concentrations. (p value =
0.010) Seventy two hours after one time exposure, serum
HDL levels were normalized, (p value = 0.381) however
3 days after chronic exposure, decreased HDL levels were
not compensated and HDL serum levels were remainedFigure 1 Serum levels of high density lipoprotein (HDL) in all studiedlow (Slightly increased but remained in the same subset
with suddenly sacrificed rats).
Parallel to the HDL changes pattern, serum paraoxonase
activity increased and decreased after acute (p value <
0.000) and chronic (p value < 0.000) ELF-MF exposure re-
spectively. After 72 hours paraoxonase serum levels were
normal in one time exposed rats, (p value = 0.931) while
its serum levels remained low in two weeks ELF MF ex-
posed rats (p value = 0.006).
Serum TA levels were increased after one time ELF
MF exposure. On the other hand, in chronic exposed
rats TA levels were decreased significantly. Three days
after single exposure serum TA levels were normalized,
(p value = 0.997) while in chronic exposed rats serum TAgroups.
Figure 2 Serum paraoxonase (PON) activity in all studied groups.
Figure 3 Serum levels of total antioxidant (TA) in all studied groups.
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Figure 4 Serum levels of malondehaldeid (MDA) in all studied groups.
Figure 5 Serum levels of conjugated diens (CD) in all studied groups.
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Figure 6 Serum levels of free fatty acids (FFA) in all studied groups.
Figure 7 Serum levels of low density lipoprotein (LDL) in all studied groups.
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sham exposed group (p value < 0.000).
Discussion
This study was undertaken to evaluate effects of acute
and chronic ELF-MF exposure on serum lipid profile,
lipid peroxidation, antioxidant system, and paraoxonase
activity as mediators protecting against atherogenesis
and atherosclerosis.
According to the results of our study, ELF-MF expos-
ure changed lipid profile, increased lipid peroxidation,
and affected antioxidant system.
Paraoxonase, HDL and serum total antioxidant cap-
acity parallel alterations reflects their similar functions
as measurements of antioxidant system. In this study,
one time acute exposure to ELF-MF slightly increased
their serum levels which showed that antioxidant system
has been evoked. These mediators levels were normalized
after 3 days in short time exposure, however after chronic
exposure, antioxidant capacity remained low after 72 hours.
Antioxidant capacity could be repaired after exposure, but
its’ ability to repair is dependent on duration and continuity
of ELF-MF exposure. It should be noted that observed
differences in HDL levels were not clinically significant;
clinical significance of the above statistically observed differ-
ences needs further evaluation.
To the best of our knowledge, this is the first study
evaluating the paraoxonase alterations after acute and
chronic ELF-MF exposure. According to the results of
Torres-Duran et al. serum HDL levels were increased
after acute one time exposure to ELF- MF (Hz). Their
results were in accordance with our findings. [15] It has
been shown that paraoxonase has antioxidant properties
and could prevent cell-mediated oxidative modification
of low density lipoprotein [7]; hence, impaired paraoxo-
nase activity could increase risk of atherosclerosis due to
increased lipoprotein peroxidation [6].
LDL seems to be the impervious particle in this study.
No significant differences were observed between LDL
levels of different groups. Although increased levels of free
fatty acids in our study might indicate that metabolism of
lipids were increased after ELF-MF exposure. Most previ-
ous reports suggest that ELF-MF exposure might increase
lipid metabolism [15]. Torres-Duran et al. observed that
one time exposure to ELF-MF significantly decreased total
cholesterol levels and increased lipid peroxide content in
the liver. Serum free fatty acids level were increased in
their exposed rats compared to their control sham ex-
posed rats [15]. Nitric oxide synthase stimulation by ELF-
MF may explain these findings. CD and MDA levels were
increased after ELF-MF exposure in our study. Surprisingly,
even one time exposure to ELF-MF increased CD levels as
an early stage marker of lipid peroxidation. While after
72 hours, CD levels were normalized but MDA levelsincreased as the late stage marker of peroxidation. Chronic
exposure tends to increased levels of CD and MDA. Due to
the kinetic of CD particle, its serum levels were normalized
after 72 hours but MDA serum levels remained high. This
was predictable due to short half life of CD particles as early
markers of lipid peroxidation. MDA prolonged half life ex-
plains observed steady state of MDA levels after 72 hours.
According to the study by Zwirska-Korczala et al., ELF-
MF exposure increased lipid peroxidation in cultured
3 T3-L1 pre-adipocyte [3]. Erdal et al. suggested that
ELFMF exposure could increase nitrosative-oxidative
stress in liver tissue [16]. Ayata et al. showed that Expos-
ure to mobile phone waves increased lipid peroxidation
and fibrosis in Rat skin [4]. Lee et al. suggested that ELF-
MF exposure affects antioxidant system by production of
free reactive oxygen species ROS [10]. Atherosclerosis is a
chronic process, and chronic lipid peroxidation by ELF-
MF exposure theoretically might increase the risk of
atherosclerosis.
It is well known that inflammation and oxidative stress
are closely linked while oxidative stress evokes inflam-
mation; on the other hand inflammation increases oxida-
tive stress via production of reactive oxygen species
through inflammatory cells. In a recent published study
by Jonai et al. ELF-MF exposure decreased TNF-α pro-
duction in the human peripheral blood mononuclear
cells (h-PBMCs). Interleukin 1-B production was in-
creased and Interferon-γ production was decreased at
some point of exposure [17]. IL-1 is an inflammatory
stimulating cytokine; increased production of IL-1 could
increase oxidative stress. Surprisingly, there are some re-
ports suggesting ELF-MF as anti-inflammatory mediator
in treatment of inflammatory conditions [18,19]. How-
ever as we mentioned above, most of recent published
articles are in line with the results obtained in our study
implying ELF-MF exposure as mediator of oxidative
stress [4,10,16,20]. Akdag et al. showed that ELF-MF ex-
posure (100 and 500 micro T) implemented oxidative
stress, diminished antioxidant defense system and had
toxic effects on brain of exposed rats [20]. According to
the results of a recent published study by Jelenkovic
et al., ELF-MF exposure increased lipid peroxidation in
frontal cortex, forebrain and basal areas in the brain of
exposed rats. Superoxide anion production was also in-
creased in all areas of brain in exposed rats. They sug-
gested that NO2 signaling pathways might be affected by
NO2 reaction with superoxide onions [5].
According to the results of our study, one time ELF-
MF exposure increased lipid peroxidation (CD and
MDA) and increased antioxidant serum activity (HDL,
paraoxonase activity, and serum total antioxidant cap-
acity). Chronic ELF-MF exposure increased lipid peroxi-
dation and affected antioxidant system. Free fatty acids
levels were increased after both one time and two weeks
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while acute exposure tended to reversible alterations on
above mentioned parameters. It seems that ELF-MF ex-
posure implements an effect which evokes antioxidant
system to recompense toxic effects of reactive oxygen spe-
cies; however, in chronic ELF-MF exposure antioxidant
system is exhausted and oxidative stress and resulted lipid
peroxidation is dramatically increased as a consequence.
Glutathion peroxidase levels as a valuable marker of
oxidative stress were not measured in this study. Clinical
significance of observed changes in measured parame-
ters needs further evaluations.
Oxidant-antioxidant pathways are extremely complex
and it should keep in mind that uncontrolled and over the
counter consumption of any supplement could accom-
pany by several unfavorable and hazardous effects [21].
Manipulation and modification of oxidant-antioxidants
pathway needs accurate knowledge of this complex sys-
tem. Hence, our findings and even the results of larger
clinical studies do not warranty benefits of antioxidants
consumption.
In conclusion, ELF- MF exposure could impair oxidant-
antioxidant balance and might increase oxidative stress
and lipid peroxidation. Antioxidant defect could be
repaired after exposure; however it might depends on the
duration and continuity of ELF-MF exposure.
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